beta-alanine has been researched along with B16 Melanoma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Flook, AM | 1 |
Yang, J | 1 |
Miao, Y | 1 |
Eike, LM | 1 |
Mauseth, B | 1 |
Camilio, KA | 1 |
Rekdal, Ø | 1 |
Sveinbjørnsson, B | 1 |
Jang, BS | 1 |
Lim, E | 1 |
Hee Park, S | 1 |
Shin, IS | 1 |
Danthi, SN | 1 |
Hwang, IS | 1 |
Le, N | 1 |
Yu, S | 1 |
Xie, J | 1 |
Li, KC | 1 |
Carrasquillo, JA | 1 |
Paik, CH | 1 |
3 other studies available for beta-alanine and B16 Melanoma
Article | Year |
---|---|
Substitution of the Lys linker with the β-Ala linker dramatically decreased the renal uptake of 99mTc-labeled Arg-X-Asp-conjugated and X-Ala-Asp-conjugated α-melanocyte stimulating hormone peptides.
Topics: alpha-MSH; Animals; beta-Alanine; Dipeptides; Female; Kidney; Liver; Lysine; Melanoma, Experimental; | 2014 |
The Cytolytic Amphipathic β(2,2)-Amino Acid LTX-401 Induces DAMP Release in Melanoma Cells and Causes Complete Regression of B16 Melanoma.
Topics: Adenosine Triphosphate; Animals; Antimicrobial Cationic Peptides; Antineoplastic Agents; beta-Alanin | 2016 |
Radiolabeled high affinity peptidomimetic antagonist selectively targets alpha(v)beta(3) receptor-positive tumor in mice.
Topics: Animals; beta-Alanine; Humans; Indium Radioisotopes; Injections, Intraperitoneal; Integrin alphaVbet | 2007 |